Literature DB >> 15700144

New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.

Holger M Koch1, Hermann M Bolt, Ralf Preuss, Jürgen Angerer.   

Abstract

The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied after three doses of 0.35 mg (4.7 microg/kg), 2.15 mg (28.7 microg/kg) and 48.5 mg (650 microg/kg) of D4-ring-labelled DEHP were administered orally to a male volunteer. Two new metabolites, mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44 h in urine and for 8 h in serum for the high-dose case, in addition to the three metabolites previously analysed: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases, 24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after 24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and 2cx-MMHP were between 15 and 24 h. After 24 h 67.0% (range: 65.8-70.5%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP (23.3%), 5cx-MEPP (18.5%), 5oxo-MEHP (15.0%), MEHP (5.9%) and 2cx-MMHP (4.2%). An additional 3.8% of the DEHP dose was excreted on the second day, comprising 2cx-MMHP (1.6%), 5cx-MEPP (1.2%), 5OH-MEHP (0.6%) and 5oxo-MEHP (0.4%). In total about 75% of the administered DEHP dose was excreted in urine after two days. Therefore, in contrast to previous studies, most of the orally administered DEHP is systemically absorbed and excreted in urine. No dose dependency in metabolism and excretion was observed. The secondary metabolites of DEHP are superior biomonitoring markers compared to any other parameters, such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary metabolites are unsusceptible to contamination. Furthermore, there are strong hints that the secondary oxidised DEHP metabolites-not DEHP or MEHP-are the ultimate developmental toxicants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700144     DOI: 10.1007/s00204-004-0642-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  94 in total

1.  Biomarkers of exposure to triclocarban in urine and serum.

Authors:  Xiaoyun Ye; Xiaoliu Zhou; Johnathan Furr; Ki Chang Ahn; Bruce D Hammock; Earl L Gray; Antonia M Calafat
Journal:  Toxicology       Date:  2011-05-23       Impact factor: 4.221

2.  Prenatal Exposure to DEHP Induces Premature Reproductive Senescence in Male Mice.

Authors:  Radwa Barakat; Po-Ching Patrick Lin; Saniya Rattan; Emily Brehm; Igor F Canisso; Mohamed E Abosalum; Jodi A Flaws; Rex Hess; CheMyong Ko
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

Review 3.  Exposure assessment issues in epidemiology studies of phthalates.

Authors:  Lauren E Johns; Glinda S Cooper; Audrey Galizia; John D Meeker
Journal:  Environ Int       Date:  2015-08-24       Impact factor: 9.621

4.  Exposure assessment of phthalate esters in Japanese pregnant women by using urinary metabolite analysis.

Authors:  Yayoi Suzuki; Mayu Niwa; Jun Yoshinaga; Chiho Watanabe; Yoshifumi Mizumoto; Shigeko Serizawa; Hiroaki Shiraishi
Journal:  Environ Health Prev Med       Date:  2009-02-18       Impact factor: 3.674

5.  Bisphenol A and Phthalates: How Environmental Chemicals Are Reshaping Toxicology.

Authors:  Genoa R Warner; Jodi A Flaws
Journal:  Toxicol Sci       Date:  2018-12-01       Impact factor: 4.849

6.  Exposure to di-2-ethylhexyl terephthalate in a convenience sample of U.S. adults from 2000 to 2016.

Authors:  Manori J Silva; Lee-Yang Wong; Ella Samandar; James L Preau; Antonia M Calafat; Xiaoyun Ye
Journal:  Arch Toxicol       Date:  2017-03-17       Impact factor: 5.153

7.  Association of prenatal urinary phthalate metabolite concentrations and childhood BMI and obesity.

Authors:  Kim G Harley; Kimberly Berger; Stephen Rauch; Katherine Kogut; Birgit Claus Henn; Antonia M Calafat; Karen Huen; Brenda Eskenazi; Nina Holland
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

8.  Transcriptional biomarkers of steroidogenesis and trophoblast differentiation in the placenta in relation to prenatal phthalate exposure.

Authors:  Jennifer J Adibi; Robin M Whyatt; Russ Hauser; Hari K Bhat; Barbara J Davis; Antonia M Calafat; Lori A Hoepner; Frederica P Perera; Deliang Tang; Paige L Williams
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

9.  Time- and dose-related effects of di-(2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro.

Authors:  François Chauvigné; Arnaud Menuet; Laurianne Lesné; Marie-Christine Chagnon; Cécile Chevrier; Jean-François Regnier; Jürgen Angerer; Bernard Jégou
Journal:  Environ Health Perspect       Date:  2008-12-01       Impact factor: 9.031

10.  What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?

Authors:  Antonia M Calafat; Larry L Needham
Journal:  Environ Health Perspect       Date:  2009-06-24       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.